Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Using RNA-Seq, SNP-CN and Targeted Deep Sequencing To Improve The Diagnostic Paradigm In Multiple Myeloma

Michael R Rossi, PhD, Scott Newman, PhD, Ajay K. Nooka, MD, MPH, Jonathan L. Kaufman, MD, Nizar J. Bahlis, MD, Paola Neri, MD, PhD, Shannon M. Matulis, Ph.D., Leon Bernal-Mizrachi, M.D., Vikas A. Gupta, MD, PhD, Anjana Varma, M.S., Malania Wilson, M.S., Juliana DaSilva, B.S., Robert Benjamin Isett, M.S., Linsheng Zhang, MB, PhD, Debra Saxe, Ph.D., Karen P. Mann, MD, PhD, David L Jaye, MD, Lawrence H. Boise, PhD, Sagar Lonial, M.D.

Blood (2013) 122 (21): 1856.

https://doi.org/10.1182/blood.V122.21.1856.1856

Published: 2013

Journal Articles

Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis

Linsheng Zhang, MB, PhD, Sally E. Self, MD, John Lazarchick, MD

Blood (2010) 116 (21): 1903.

https://doi.org/10.1182/blood.V116.21.1903.1903

Published: 2010

Journal Articles

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

Linsheng Zhang, Florence B. Fried, Hong Guo, Alan D. Friedman

Blood (2008) 111 (3): 1193–1200.

https://doi.org/10.1182/blood-2007-08-109702

Published: 2008

Journal Articles

Cyclin-Dependent Kinase Phosphorylation of RUNX1/AML1 on Three Sites Increases Trans-Activation Potency and Stimulates Cell Proliferation.

Alan D. Friedman, MD, Linsheng Zhang, M.D., Ph.D., Florence Bernardin Fried, Ph.D.

Blood (2007) 110 (11): 3351.

https://doi.org/10.1182/blood.V110.11.3351.3351

Published: 2007

Journal Articles

Mutational Analysis of the CBFβ-SMMHC Assembly Competence Domain Identifies a Surface Critical for Multimerization and Inhibition of RUNX1/AML1.

Linsheng Zhang, Jenice D’Costa, Tanawan Kummalue, Isabel Moreno, Curt I. Civin, Scott W. Hiebert, Alan D. Friedman

Blood (2005) 106 (11): 2853.

https://doi.org/10.1182/blood.V106.11.2853.2853

Published: 2005

Journal Articles

Multimerization and Corepression Mediated by the CBFβ-SMMHC Assembly Competence Domain Are Partially Separable and Corepression Is Required to Inhibit Core Binding Factor Activities.

Linsheng Zhang, Ph.D., Scott W. Hiebert, Ph.D., Alan D. Friedman, M.D.

Blood (2004) 104 (11): 1972.

https://doi.org/10.1182/blood.V104.11.1972.1972

Published: 2004

NARROW

Using RNA-Seq, SNP-CN and Targeted Deep Sequencing To Improve The Diagnostic Paradigm In Multiple Myeloma

Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

Cyclin-Dependent Kinase Phosphorylation of RUNX1/AML1 on Three Sites Increases Trans-Activation Potency and Stimulates Cell Proliferation.

Mutational Analysis of the CBFβ-SMMHC Assembly Competence Domain Identifies a Surface Critical for Multimerization and Inhibition of RUNX1/AML1.

Multimerization and Corepression Mediated by the CBFβ-SMMHC Assembly Competence Domain Are Partially Separable and Corepression Is Required to Inhibit Core Binding Factor Activities.

Email alerts

ASH Publications

American Society of Hematology

Using RNA-Seq, SNP-CN and Targeted Deep Sequencing To Improve The Diagnostic Paradigm In Multiple Myeloma

Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

Cyclin-Dependent Kinase Phosphorylation of RUNX1/AML1 on Three Sites Increases Trans-Activation Potency and Stimulates Cell Proliferation.

Mutational Analysis of the CBFβ-SMMHC Assembly Competence Domain Identifies a Surface Critical for Multimerization and Inhibition of RUNX1/AML1.

Multimerization and Corepression Mediated by the CBFβ-SMMHC Assembly Competence Domain Are Partially Separable and Corepression Is Required to Inhibit Core Binding Factor Activities.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only